Results 231 to 240 of about 442,297 (356)

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Imaging findings of thyroid diseases in children. [PDF]

Clin Pediatr Endocrinol
Tsujioka Y, Yamada Y, Hasegawa T, Hashimoto M, Jinzaki M.   +4 more
europepmc   +1 more source

Fetal cell microchimerism: a protective role in autoimmune thyroid diseases [PDF]

, 2015
Valentina Cirello, Roberta Rizzo, M. Crippa, Irene Campi, Daria Bortolotti, Silvia Bolzani, Carla Colombo, Guia Vannucchi, Maria Antonia Maffini, Federica de Liso, Stefano Ferrero, Palma Finelli, Laura Fugazzola   +12 more
openalex   +1 more source

Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
A considerable number of oral antitumor therapeutics (OAT) has the potential for causing pseudo‐worsening of kidney function (PW) due to inhibition of renal creatinine secretion, i.e., kidney function is unaffected, while creatinine‐based calculation of glomerular filtration rate (eGFR) erroneously indicates an impaired kidney function.
Michael I. Sponfeldner, Pauline Dürr, Phyllis Lensker, Katja Gessner, Lisa Cuba, Rainer Fietkau, Markus F. Neurath, Bernd Wullich, Marianne Pavel, Carola Berking, Matthias W. Beckmann, Andreas Mackensen, Frank Dörje, Martin F. Fromm   +13 more
wiley   +1 more source

Associations between allergic diseases and autoimmune thyroid diseases: A meta-analysis of Mendelian randomization studies. [PDF]

Medicine (Baltimore)
Li J, Shen X, Han W, Xiao S, Zhang K.
europepmc   +1 more source

Development and Validation of the Singapore Thyroid Eye Disease Quality of Life Questionnaire [PDF]

, 2018
Melissa H. Wong, Eva Fenwick, Ai Tee Aw, Ecosse L. Lamoureux, Lay Leng Seah   +4 more
openalex   +1 more source

Thyroid heart disease. [PDF]

Heart, 1979
openaire   +2 more sources

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

Clinical Pharmacology &Therapeutics, EarlyView.
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg, Maaike M. Hofman, Fatima Ashad, Alaa Daloul, Stefani Oosterveld, Edwin A. Basak, Esther Oomen‐de Hoop, Astrid A. M. van der Veldt, Arjen Joosse, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen   +10 more
wiley   +1 more source

Clinical management of alemtuzumab-induced autoimmune thyroid diseases: a narrative review. [PDF]

Eur Thyroid J
Manso J, Muller I, Mian C.
europepmc   +1 more source

Quality of life in patients with thyroid eye disease.

, 2009
Mohsen Bahmani Kashkouli, Farzad Pakdel, Arezoo Astaraki, Masih Hashemi, Yasamin Honarbakhsh, Bahareh Mirarmandehi, Sara Jam   +6 more
openalex   +1 more source